- 801. 17ad
- [Mandibular left third molar abutment distal hemisection ( HL7V3.0 )] (UMLS (HL7) C1553651) =Medical Device =Artificial dentition;
| - 851. 1a
- [Maxillary right third molar abutment ( HL7V3.0 )] (UMLS (HL7) C1553633) =Medical Device =Artificial dentition;
|
- 802. 17alpha-Hydroxy-6alpha-methylpregn-4-ene-3,20-dione
- [principal progestational hormone, secreted by the corpus luteum, placenta, and in minute amounts by the adrenal cortex; it prepares the uterus for the reception and development of the fertilized ovum; it acts on the mammary glands and on the brain; it serves as an intermediate in the biosynthesis of sex steroids and adrenal corticosteroids. ( CSP )] (UMLS (NCI) C0033308) =Steroid; Pharmacologic Substance; Hormone =C21 steroid;
Pregnenediones;
[HS800] PROGESTINS;
gonadal steroid hormone =HYDROXYPROGESTERONE;
(6Alpha)-17-hydroxy-6-methylpregn-4-ene-3,20-dione;
PROGESTERONE 2.5 MG;
PROGESTERONE 25 MG/ML;
PROGESTERONE 50 MG/ML;
PROGESTERONE 100 MG;
PROGESTERONE PWDR;
PROGESTERONE 200 MG;
PROGESTERONE 8 %;
PROGESTERONE 4 %;
| - 852. 1alphaH,5alphaH-Tropan-3alpha-ol, 6beta,7beta-epoxy-,(-)-tropate(ester)
- [anticholinergic alkaloid. ( CSP )] (UMLS (NCI) C0036442) =Organic Chemical; Pharmacologic Substance =alkaloid;
Belladonna Alkaloids;
1alphaH,5alphaH-Tropan-3alpha-ol, 6beta,7beta-epoxy-,(-)-tropate(ester);
tropane;
Anticholinergic Agent;
[CN550] ANTIVERTIGO AGENTS =1alphaH,5alphaH-Tropan-3alpha-ol, 6beta,7beta-epoxy-,(-)-tropate(ester);
Scopolamine Derivatives;
HYOSCINE HYDROBROMIDE;
SCOPOLAMINE 0.33 MG |
- 803. 17am
- [Mandibular left third molar abutment mesial hemisection ( HL7V3.0 )] (UMLS (HL7) C1553650) =Medical Device =Artificial dentition;
| - 853. 1alphaH,5alphaH-Tropanium, 6beta,7beta-epoxy-3alpha-hydroxy-8-methyl-, bromide,(-)-tropate(8CI)
- [The bromide salt form of methscopolamine, a quaternary ammonium derivative of scopolamine with anticholinergic properties. Methscopolamine bromide exerts its effect on muscarine receptors in the gastrointestinal tract, thereby blocking the actions of acetylcholine. This leads to an inhibition of gastric secretions and gastrointestinal motility. ( NCI )] (UMLS (NCI) C0141756) =Organic Chemical; Pharmacologic Substance =METHSCOPOLAMINE;
=METHSCOPOLAMINE BROMIDE 2.5 MG |
- 804. 17beta-(estra-1,3,5(10)-triene-3,17-diol 3-[bis(2-chloroethyl)carbamate]
- [A combination of the hormone estradiol (an estrogen) and nitrogen mustard (an anticancer drug). Used in the palliative therapy of prostate cancer. ( NCI )] (UMLS (NCI) C0014921) =Steroid; Pharmacologic Substance ;
=[AN000] ANTINEOPLASTICS;
(17beta)-Estra-1,3,5(10)-triene-3,17-diol;
Nitrogen Mustard Compound;
=Estramustine 17-(Dihydrogenphosphate) Disodium Salt;
| - 854. 1D1O Anti-lymphoma Antibody
- [A type of monoclonal antibody that is being studied as a treatment for hematologic (blood) cancers. ( NCI )] (UMLS (NCI) C1122758) Apolizumab =Amino Acid, Peptide, or Protein; Pharmacologic Substance; Immunologic Factor
|
- 805. 17Beta-Cyclopentanepropionate
- [An eight-carbon ester form of Testosterone. The number of ester carbon atoms correlate with the half-life of the prodrug. Testosterone inhibits gonadotropin secretion from the pituitary gland and ablates estrogen production in the ovaries, thereby decreasing endogenous estrogen levels. In addition, this agent promotes the maintenance of male sex characteristics and is indicated for testosterone replacement in hypogonadal males. (NCI04) ( NCI )] (UMLS (NCI) C0076181) =Steroid; Pharmacologic Substance ;
=(17Beta)-17-hydroxyandrost-4-en-3-one;
=TESTOSTERONE CYPIONATE 100 MG/ML;
TESTOSTERONE CYPIONATE 50 MG/ML;
TESTOSTERONE CYPIONATE 200 MG/ML | - 855. 1H-1,2,3-Triazole-4-carboxamide, 5-amino-1-((3,5-dichloro-4(4-chlorobenzoyl)phenyl)methyl)
- [An anticancer drug that belongs to the family of drugs called angiogenesis inhibitors. ( NCI )] (UMLS (NCI) C0064494) =Organic Chemical; Pharmacologic Substance ;
|
- 806. 17beta-Estradiol 17-Cyclopentylpropionate
- [The cypionate salt form of estradiol, the most potent, naturally produced estrogen. Estradiol cypionate diffuses through the cell membrane and binds to and subsequently activates the nuclear estrogen receptor found in the reproductive tract, breast, pituitary, hypothalamus, liver, and bone. The activated complex binds to the estrogen response element on the DNA and activates the transcription of genes involved in the functioning of the female reproductive system and secondary sex characteristics. ( NCI )] (UMLS (NCI) C0059610) =Steroid; Pharmacologic Substance; Hormone =(17beta)-Estra-1,3,5(10)-triene-3,17-diol;
=ESTRADIOL CYPIONATE 5 MG;
ESTRADIOL CYPIONATE 2 MG/ML;
ESTRADIOL CYPIONATE 5 MG/ML;
| - 856. 1H-1,2,4-Triazol-3-Amine
- [A colorless, odorless crystalline, aromatic amine with a bitter taste. Amitrole is a widely used herbicide for nonfood croplands to control annual and perennial grass type weeds, pondweeds and broad leaf. This substance has a very low acute toxicity in humans and is characterized by skin rash, diarrhea, nausea, vomiting and nose bleeds. Amitrole is reasonably anticipated to be a human carcinogen. (NCI05) ( NCI )] (UMLS (NCI) C0002602) =Organic Chemical; Hazardous or Poisonous Substance
|
- 807. 17Beta-hydroxyestra-1,3,5(10)-trien-3-yl Acetate
- [The acetate salt form of estradiol, the most potent, naturally produced estrogen. Estradiol acetate diffuses through the cell membrane and binds to and subsequently activates the nuclear estrogen receptor found in the reproductive tract, breast, pituitary, hypothalamus, liver, and bone. The activated complex binds to the estrogen response element on the DNA and activates the transcription of genes involved in the functioning of the female reproductive system and secondary sex characteristics. ( NCI )] (UMLS (NCI) C1330622) Estradiol Acetate;
ESTRADIOL ACETATE UNIDENTIFIED;
ESTRADIOL ACETATE UNIDENTIFIED =Steroid; Pharmacologic Substance; Hormone | - 857. 1H-1,4-Benzodiazepine-3-carboxylic acid, 7-chloro-2,3-dihydro-2-oxo-5-phenyl-, Monopotassium Salt, compound with Potassium Hydroxide
- [A benzodiazepine with anxiolytic, sedative, hypnotic, and anticonvulsant properties. Clorazepate dipotassium exerts its effect by de-activating the nervous system through potentiation of the inhibitory effect of gamma-aminobutyric acid (GABA) on the GABA-A receptors by binding to a site that is distinct from the GABA binding site. Its inhibitory effect is caused by an increase in GABA-mediated chloride channel opening events, leading to hyperpolarization and synaptic inhibition. ( NCI )] (UMLS (NCI) C0009033) =Organic Chemical; Pharmacologic Substance ;
=benzodiazepine;
CLORAZEPATE PREPARATION =CLORAZEPATE DIPOTASSIUM 15 MG;
CLORAZEPATE DIPOTASSIUM 22.5 MG;
CLORAZEPATE DIPOTASSIUM 7.5 MG;
CLORAZEPATE DIPOTASSIUM 11.25 MG;
CLORAZEPATE DIPOTASSIUM 3.75 MG;
|
- 808. 17d
- [Mandibular left third molar distal hemisection ( HL7V3.0 )] (UMLS (HL7) C1552104) =Body Part, Organ, or Organ Component =Permanent dentition;
| - 858. 1H-Benz(de)isoquinolin-1-one, 2-(3S)-1-azabicyclo(2.2.2)oct-3-yl-2,3,3a,4,5,6-hexahydro-, Monohydrochloride,(3aS)-
- [The hydrochloride salt form of palonosetron, a carbazole derivative and a selective serotonin receptor antagonist with antiemetic properties. Palonosetron competitively blocks the action of serotonin at 5-HT3 receptors located on vagal afferents in the chemoreceptor trigger zone (CTZ), resulting in suppression of chemotherapy-induced nausea and vomiting. ( NCI )] (UMLS (NCI) C1310734) PALONOSETRON HCL UNIDENTIFIED;
PALONOSETRON HCL UNIDENTIFIED;
PALONOSETRON HYDROCHLORIDE;
=Organic Chemical; Pharmacologic Substance ;
|
- 809. 17i
- [Mandibular left third molar implant ( HL7V3.0 )] (UMLS (HL7) C1552181) =Medical Device =Artificial dentition;
| - 859. 1H-benz(de)isoquinoline-1,3(2H)-dione, 5-amino-2-(2-(dimethylamino)ethyl)
- (UMLS (NCI) C0051733) =Organic Chemical; Pharmacologic Substance
|
- 810. 17id
- [Mandibular left third molar implant distal hemisection ( HL7V3.0 )] (UMLS (HL7) C1552183) =Medical Device =Artificial dentition;
| - 860. 1H-benzimidazol-2-ylcarbamic Acid Methyl Ester
- [An anticancer drug that belongs to the family of drugs called antifungal agents. ( NCI )] (UMLS (NCI) C0065839) =Organic Chemical; Pharmacologic Substance; Hazardous or Poisonous Substance
|
- 811. 17im
- [Mandibular left third molar implant mesial hemisection ( HL7V3.0 )] (UMLS (HL7) C1552182) =Medical Device =Artificial dentition;
| - 861. 1H-Carbazole-6-carboxamide, 2,3,4,9-tetrahydro-3-(methylamino)-,(3R)-, Butanedioate(1:1)
- [The succinate salt form of frovatriptan, a synthetic triptan with serotonin (5-HT) receptor agonist activity. Frovatriptan succinate binds selectively and with high affinity to 5-HT 1B and presynaptic 5-HT 1D receptors in the extracerebral and intracranial arteries. This leads to an inhibition of serotonin activity and results in vasoconstriction of the painfully dilated blood vessels during migraine attack. Frovatriptan succinate is indicated for the acute treatment of migraine. (NCI05) ( NCI )] (UMLS (NCI) C1099777) Frovatriptan Succinate;
FROVATRIPTAN SUCCINATE UNIDENTIFIED;
=Organic Chemical; Pharmacologic Substance |
- 812. 17m
- [Mandibular left third molar mesial hemisection ( HL7V3.0 )] (UMLS (HL7) C1552103) =Body Part, Organ, or Organ Component =Permanent dentition;
| - 862. 1H-Imidazo(4,5-c)quinolin-4-amine, 1-(2-methylpropyl)-
- [A substance that improves the body's natural response to infection and disease. It is being studied as a topical agent (something used on the surface of the body) for the prevention of some types of cancer. It belongs to the family of drugs called biological response modifiers. ( NCI )] (UMLS (NCI) C0165032) =Organic Chemical; Pharmacologic Substance =S 26308;
[IM900] IMMUNOLOGICAL AGENTS, OTHER =IMIQUIMOD 5 % |
- 813. 17p
- [Mandibular left third molar prosthesis ( HL7V3.0 )] (UMLS (HL7) C1553586) =Body Part, Organ, or Organ Component =Artificial dentition;
| - 863. 1H-Imidazole, 1-(2-((7-chlorobenzo(b)thien-3-yl)methoxy)-2-(2,4-dichlorophenyl)ethyl)-, Mononitrate
- [The nitrate salt form of sertaconazole, a synthetic imidazole derivative with antifungal property. Sertaconazole nitrate inhibits fungal cytochrome P-450 sterol C-14 alpha-demethylation, resulting in the accumulation of fungal 14 alpha-methyl sterols and the inhibition of ergosterol synthesis, an essential component of the cell membrane of fungi. This leads to a disruption of cell membrane permeability and leakage of adenine triphosphate (ATP) and other constituents from fugal cells. ( NCI )] (UMLS (NCI) C0771896) Sertaconazole Nitrate;
=Organic Chemical; Pharmacologic Substance |
- 814. 17p
- [Proximal (short) arm of chromosome 17 ( NCI )] (UMLS (NCI) C0796349) Chromosome 17 Proximal Arm;
Chromosome 17 Short Arm;
Chromosome 17p =Nucleotide Sequence | - 864. 1H-Imidazole, 4,5-dihydro-2-(1,2,3,4-tetrahydro-1-naphthalenyl)-, Monohydrochloride
- [The hydrochloride salt form of tetrahydrozoline, an imidazole derivative with sympathomimetic property. Applied locally to the eye or nose, tetrahydrozoline binds to and activates alpha-adrenergic receptors, resulting in vasoconstriction and decreased nasal and ophthalmic congestion. ( NCI )] (UMLS (NCI) C0148485) =Organic Chemical; Pharmacologic Substance ;
=TETRAHYDROZOLINE;
=tetrahydrozoline 0.5 MG/ML Nasal Solution;
TETRAHYDROZOLINE HYDROCHLORIDE 0.1 %;
|
- 815. 17p12
- [A chromosome band present on 17p ( NCI )] (UMLS (NCI) C0796364) Chromosome 17p12 =Nucleotide Sequence
| - 865. 1H-Imidazole, 4,5-dihydro-2-(1-naphthalenylmethyl)-, Monohydrochloride
- [The hydrochloride salt form of naphazoline, an imidazole derivative and a direct-acting sympathomimetic amine with vasoconstrictive properties. Upon ocular administration, naphazoline hydrochloride exerts its effect by acting on alpha-adrenergic receptors in the arterioles of the conjunctiva to produce vasoconstriction, resulting in decreased conjunctival congestion and diminished itching, irritation and redness. ( NCI )] (UMLS (NCI) C0282259) =Organic Chemical; Pharmacologic Substance ;
=NAPHAZOLINE;
=NAPHAZOLINE HYDROCHLORIDE 0.025 %;
NAPHAZOLINE HYDROCHLORIDE 0.05 %;
NAPHAZOLINE HYDROCHLORIDE 0.02 %;
NAPHAZOLINE HYDROCHLORIDE 0.1 %;
NAPHAZOLINE HYDROCHLORIDE 0.012 % |
- 816. 17pd
- [Mandibular left third molar distal prosthesis ( HL7V3.0 )] (UMLS (HL7) C1553585) =Medical Device =Artificial dentition;
| - 866. 1H-Imidazole-1-acetamide, N-(2-hydroxyethyl)-2-nitro-
- [A drug that increases the effectiveness of radiation therapy. ( NCI )] (UMLS (NCI) C0059682) =Organic Chemical; Pharmacologic Substance ;
|
- 817. 17pm
- [Mandibular left third molar mesial prosthesis ( HL7V3.0 )] (UMLS (HL7) C1553587) =Medical Device =Artificial dentition;
| - 867. 1H-Imidazole-2-methanamine, 4,5-Dihydro-N-phenyl-N-(phenylmethyl)-, Phosphate(1:1)
- [The phosphate salt of antazoline, an ethylenediamine derivative with histamine H1 antagonistic and sedative properties. Antazoline antagonizes histamine H1 receptor and prevents the typical allergic symptoms caused by histamine activities on capillaries, skin, mucous membranes, gastrointestinal and bronchial smooth muscles. These histamine activities include vasodilation, bronchoconstriction, increased vascular permeability, pain, itching, and spasmodic contractions of gastrointestinal smooth muscles. Antazoline is used to provide symptomatic relieve of allergic symptoms. ( NCI )] (UMLS (NCI) C0003144) =Organic Chemical; Pharmacologic Substance
|
- 818. 17s
- [Supernumerary mandibular left third molar ( HL7V3.0 )] (UMLS (HL7) C1552131) =Body Part, Organ, or Organ Component =SUPERNUMERARY TEETH;
| - 868. 1H-imidazole-4-carboxamide, 5-(3,3-dimethyl-1-triazenyl)-
- [cytotoxic alkylating agent used as an antineoplastic primarily for treatment of malignant melanoma and in combination chemotherapy for Hodgkin's disease and sarcomas; administered intravenously; abbreviated DTIC. ( CSP )] (UMLS (NCI) C0010927) =Organic Chemical; Pharmacologic Substance =[AN000] ANTINEOPLASTICS;
imidazole;
Triazene Compound;
imidazole carboxamide =3,4-dihydro-3-methyl-4-oxoimidazo[5,1-d]-1,2,3,5-tetrazine-8-carboxamide;
DACARBAZINE 100 MG;
DACARBAZINE 200 MG;
|
- 819. 18
- [Mandibular left second molar ( HL7V3.0 )] (UMLS (HL7) C0227055) tooth 18 =Body Part, Organ, or Organ Component =Permanent dentition;
| - 869. 1H-Imidazole-5-Carboxylic Acid, 1-((1R)-1-phenylethyl)-, Ethyl Ester
- [An imidazole derivative with short-acting sedative, hypnotic, and general anesthetic properties. Etomidate appears to have gamma-aminobutyric acid (GABA) like effects, mediated through GABA-A receptor. The action enhances the inhibitory effect of GABA on the central nervous system by causing chloride channel opening events which leads to membrane hyperpolarization. ( NCI )] (UMLS (NCI) C0015131) =Organic Chemical; Pharmacologic Substance ;
=imidazole;
[CN203] GENERAL ANESTHETICS, OTHER =ETOMIDATE 2 MG/ML |
- 820. 186Re-Etidronate
- [A synthetic compound containing the radioisotope rhenium 186 and a chelator, hydroxyethylidene diphosphonate (HEDP). Re-HEDP functions as a bone-seeking radiopharmaceutical when it is mixed with bioactive material, hydroxyapatite (calcium phosphate ceramic) via intravenous infusion. Re-186 is a beta emitter, with a short half life, which provides local effects with limited distribution to extramedullary bone marrow tissues. Re-HEDP can be used to treat pain associated with primary and metastatic bone lesions. ( NCI )] (UMLS (NCI) C0280809) =Organophosphorus Compound; Pharmacologic Substance
| - 870. 1H-Imidazole-5-carboxylic Acid, 4-(1-hydroxy-1-methylethyl)-2-propyl-1-((2'-(1H-tetrazol-5-yl)(1,1'-biphenyl)-4-yl)methyl)-,(5-methyl-2-oxo-1,3-dioxol-4-yl)methyl Ester
- [A synthetic imidazole derivative prodrug with an antihypertensive property. Upon hydrolysis, olmesartan medoxomil is converted to olmesartan. Olmesartan selectively binds to the angiotensin type 1 (AT1) receptor of angiotensin II in vascular smooth muscle and adrenal gland, thereby competing angiotensin II binding to the receptor. This prevents angiotensin II-induced vasoconstriction and decreases aldosterone production, thereby preventing aldosterone-stimulated sodium retention and potassium excretion. ( NCI )] (UMLS (NCI) C0386393) =Organic Chemical; Pharmacologic Substance ;
=Olmesartan;
Unclassified Ingredients =OLMESARTAN MEDOXOMIL 20 MG;
OLMESARTAN MEDOXOMIL 40 MG;
OLMESARTAN MEDOXOMIL 5 MG |
- 821. 18a
- [Mandibular left second molar abutment ( HL7V3.0 )] (UMLS (HL7) C1553652) =Medical Device =Artificial dentition;
| - 871. 1H-imidazo[4,5-f]quinoline, acetamide deriv
- [A synthetic imidazoquinoline with antineoplastic activity. Acodazole intercalates into DNA, resulting in disruption of DNA replication. Use of this agent has been associated with significant cardiotoxicity. (NCI04) ( NCI )] (UMLS (NCI) C0050565) =Organic Chemical; Pharmacologic Substance ;
|
- 822. 18ad
- [Mandibular left second molar abutment distal hemisection ( HL7V3.0 )] (UMLS (HL7) C1553654) =Medical Device =Artificial dentition;
| - 872. 1H-Indene-3-acetic Acid, 5-Fluoro-2-methyl-1-((4-(methylsulfonyl)phenyl)methylene), (Z)
- (UMLS (NCI) C0953857) =Organic Chemical; Pharmacologic Substance
|
- 823. 18am
- [Mandibular left second molar abutment mesial hemisection ( HL7V3.0 )] (UMLS (HL7) C1553653) =Medical Device =Artificial dentition;
| - 873. 1H-Indole-2-carboxylic Acid, 1-(2-((1-(ethoxycarbonyl)butyl)amino)-1-oxopropyl)octahydro-,(2S-(1(R*(R*))2alpha,3abeta,7abeta))-, compound with 2-Methyl-2-propanamine(1:1)
- [The tert-butylamine salt of perindopril, the ethyl ester of a non-sulfhydryl angiotensin converting enzyme (ACE) inhibitor with antihypertensive property. Upon hydrolysis, perindopril erbumine is converted to its active form perindoprilat, which inhibits ACE, thereby blocks the conversion of angiotensin I to angiotensin II. This prevents angiotensin II-mediated vasoconstriction, decreases angiotensin II-stimulated aldosterone secretion from the adrenal cortex, and consequently promotes diuresis and natriuresis. ( NCI )] (UMLS (NCI) C0244718) =Organic Chemical; Pharmacologic Substance ;
=Perindopril;
=PERINDOPRIL ERBUMINE 2 MG;
PERINDOPRIL ERBUMINE 4 MG;
PERINDOPRIL ERBUMINE 8 MG |
- 824. 18d
- [Mandibular left second molar distal hemisection ( HL7V3.0 )] (UMLS (HL7) C1552106) =Body Part, Organ, or Organ Component =Permanent dentition;
| - 874. 1H-Indole-3-butanoic Acid
- (UMLS (NCI) C0063503) =Organic Chemical
|
- 825. 18F-FHBG
- [A fluorine-18 labeled acycloguanosine derivative and a reporter probe with imaging activity. Used in conjunction with adenoviral gene transfer system containing report gene for herpes simplex virus type 1 thymidine kinase (HSV1-TK), 18F-FHBG can be phosphorylated by this enzyme, thereby accumulating in the adenoviral transfected cells. This allows for assessment of transfection tissue location and efficiency of gene transfer. ( NCI )] (UMLS (NCI) C0754974) 9-(4-18F-Fluoro-3-[hydroxymethyl]butyl)guanine;
Reporter Probe 18F-FHBG;
=Nucleic Acid, Nucleoside, or Nucleotide | - 875. 1H-Indole-3-ethanamine, N,N-dimethyl-5-(1H-1,2,4-triazol-1-ylmethyl)-, Monobenzoate
- [The benzoate salt form of rizatriptan, a member of the triptan class agents with anti-migraine property. Rizatriptan benzoate selectively binds to and activates serotonin (5-HT) 1B receptors expressed in intracranial arteries, and to 5-HT 1D receptors located on peripheral trigeminal sensory nerve terminals in the meninges and central terminals in brain stem sensory nuclei. Receptor binding results in constriction of cranial vessels and inhibition of nociceptive transmission, thereby providing relief of migraine headaches. Rizatriptan benzoate may also relief migraine headaches by inhibition of pro-inflammatory neuropeptide release. ( NCI )] (UMLS (NCI) C0772420) Rizatriptan Benzoate;
RIZATRIPTAN BENZOATE PREPARATION =Organic Chemical; Pharmacologic Substance ;
=RIZATRIPTAN;
=RIZATRIPTAN BENZOATE 10 MG;
RIZATRIPTAN BENZOATE 5 MG |
- 826. 18FDG
- [The radioactive form of glucose used in positron emission tomography (PET), a diagnostic imaging procedure. ( NCI )] (UMLS (NCI) C0046056) =Organic Chemical; Indicator, Reagent, or Diagnostic Aid ;
| - 876. 1H-indole-3-methanol
- [A substance that is being studied as a cancer prevention drug. It is found in cruciferous vegetables. ( NCI )] (UMLS (NCI) C0063491) =Organic Chemical; Pharmacologic Substance ;
|
- 827. 18i
- [Mandibular left second molar implant ( HL7V3.0 )] (UMLS (HL7) C1552184) =Medical Device =Artificial dentition;
| - 877. 1H-Purin-6-amine
- [6-aminopurine; one of the 5 major bases (with guanine, thymine, cytosine, and uracil) found in nucleic acids. ( CSP )] (UMLS (NCI) C0001407) =Nucleic Acid, Nucleoside, or Nucleotide; Biologically Active Substance ;
|
- 828. 18id
- [Mandibular left second molar implant distal hemisection ( HL7V3.0 )] (UMLS (HL7) C1552186) =Medical Device =Artificial dentition;
| - 878. 1H-Purin-6-amine, 2-fluoro- (9CI)
- [A fluorinated heterocyclic 2-ring compound. 2-fluoroadenine is the base moiety for many carbocyclic and acyclic nucleoside analogues, which may be used in antineoplastic studies. ( NCI )] (UMLS (NCI) C0046110) =Nucleic Acid, Nucleoside, or Nucleotide
|
- 829. 18im
- [Mandibular left second molar implant mesial hemisection ( HL7V3.0 )] (UMLS (HL7) C1552185) =Medical Device =Artificial dentition;
| - 879. 1H-Purine-2,6-diamine
- [One of a number of organic compounds that share a similar purine structure and possess antiviral and antitumor properties. 2,6-Diaminopurine nucleosides are versatile synthetic precursors for specific N-6 modifications of antiviral and antitumor agents. (NCI04) ( NCI )] (UMLS (NCI) C0045587) =Nucleic Acid, Nucleoside, or Nucleotide; Pharmacologic Substance ;
|
- 830. 18m
- [Mandibular left second molar mesial hemisection ( HL7V3.0 )] (UMLS (HL7) C1552105) =Body Part, Organ, or Organ Component =Permanent dentition;
| - 880. 1H-Purine-2,6-dione, 3,7-dihydro-1,3-dimethyl-, compound with 1,2-Ethanediamine(2:1)
- [drug combination that contains theophylline and ethylenediamine; its most common use is in bronchial asthma, but it has been investigated for several other applications. ( CSP )] (UMLS (NCI) C0002575) =Organic Chemical; Pharmacologic Substance
|
- 831. 18p
- [Mandibular left second molar prosthesis ( HL7V3.0 )] (UMLS (HL7) C1553589) =Body Part, Organ, or Organ Component =Artificial dentition;
| - 881. 1H-Purine-2,6-dione, 7-(2,3-dihydroxypropyl)-3,7-dihydro-1,3-dimethyl
- [A xanthine derivative. Dyphilline exerts bronchodilator effects and to a lesser extent vasodilator and diuretic properties. Dyphilline probably acts as a competitive inhibitor of phosphodiesterase which leads to an increase in intracellular cAMP. This results in relaxation of bronchial smooth muscle and other smooth muscles. Dyphylline may also antagonize adenosine receptors. Dyphylline is used in the treatment of acute bronchial asthma, chronic bronchitis and emphysema. ( NCI )] (UMLS (NCI) C0013360) =Organic Chemical; Pharmacologic Substance =3,7-Dihydro-1,3-dimethyl-1H-purine-2,6-dione;
[RE104] BRONCHODILATORS, XANTHINE-DERIVATIVE;
TO BE DELETED INGREDIENT PREPARATIONS;
=DYPHYLLINE 125 MG/ML;
Dyphylline 20 MG/ML;
DYPHYLLINE 200 MG;
DYPHYLLINE 250 MG/ML;
DYPHYLLINE 400 MG;
DYPHYLLINE 100 MG/15ML;
Dyphylline 10.7 MG/ML;
DYPHYLLINE 100 MG |
- 832. 18pd
- [Mandibular left second molar distal prosthesis ( HL7V3.0 )] (UMLS (HL7) C1553588) =Medical Device =Artificial dentition;
| - 882. 1H-Pyrazole, 4-methyl-
- [A pyrazole with competitive alcohol dehydrogenase inhibitor activity. Fomepizole prevents the metabolism of ethylene glycol and methanol by alcohol dehydrogenase, thereby inhibiting the formation of their toxic metabolites, glycolate and oxalate (from ethylene glycol), and formic acid (from methanol). Fomepizole is indicated for use as an antidote in ethylene glycol and methanol poisoning. (NCI05) ( NCI )] (UMLS (NCI) C0048504) =Organic Chemical; Pharmacologic Substance =Pyrazole Compound;
1H-Pyrazole, 4-methyl-;
[AD900] ANTIDOTES/DETERRENTS, OTHER;
=1H-Pyrazole, 4-methyl-;
FOMEPIZOLE 1 GM/ML;
|
- 833. 18pm
- [Mandibular left second molar mesial prosthesis ( HL7V3.0 )] (UMLS (HL7) C1553590) =Medical Device =Artificial dentition;
| - 883. 1H-Pyrido(4,3-b)indol-1-one, 2,3,4,5-tetrahydro-5-methyl-2((5-methyl-1H-imidazol-4-yl)methyl)-, Monohydrochloride
- [The chloride salt form of alosetron, a potent and selective 5-HT3 receptor antagonist. Alosetron hydrochloride blocks the actions of serotonin at 5-HT3 sites in the peripheral nervous system, particularly on enteric and nociceptive sensory neurons. Alosteron hydrochloride affects the regulation of visceral pain, decreases gastrointestinal contraction and motility, and decreases gastrointestinal secretions. This drug is used to treat diarrhea-predominant irritable bowel syndrome in women. (NCI05) ( NCI )] (UMLS (NCI) C0291771) =Organic Chemical; Pharmacologic Substance =alosetron;
|
- 834. 18q
- [Distal (long) arm of chromosome 18 ( NCI )] (UMLS (NCI) C0796350) Chromosome 18 Distal Arm;
Chromosome 18 Long Arm;
Chromosome 18q =Nucleotide Sequence | - 884. 1i
- [Maxillary right third molar implant ( HL7V3.0 )] (UMLS (HL7) C1552165) =Medical Device =Artificial dentition;
|
- 835. 18s
- [Supernumerary mandibular left second molar ( HL7V3.0 )] (UMLS (HL7) C1552132) =Body Part, Organ, or Organ Component =SUPERNUMERARY TEETH;
| - 885. 1p
- [Maxillary right third molar prosthesis ( HL7V3.0 )] (UMLS (HL7) C1552210) =Medical Device =Artificial dentition;
|
- 836. 18S Ribosomal RNA
- [The second largest of the three RNA components of the mammalian ribosome. ( NCI )] (UMLS (NCI) C0035703) =Nucleic Acid, Nucleoside, or Nucleotide; Biologically Active Substance
| - 886. 1p
- [Proximal (short) arm of chromosome 1 ( NCI )] (UMLS (NCI) C1327810) Chromosome 1 Proximal Arm;
Chromosome 1 Short Arm;
Chromosome 1p =Nucleotide Sequence ;
|
- 837. 19
- [The first, permanent, six-year molar of the lower left arch as defined by the Universal tooth numbering system. ( NCI )] (UMLS (HL7) C0227056) tooth 19 =Body Part, Organ, or Organ Component =Permanent dentition;
| - 887. 1pd
- [Maxillary right third molar distal prosthesis ( HL7V3.0 )] (UMLS (HL7) C1552209) =Medical Device =Artificial dentition;
|
- 838. 19 nortestosterone
- [A synthetic, anabolic steroid analog of testosterone. Similar to testosterone, nortestosterone (19-Nortestosterone) binds to and activates specific nuclear receptors. This agent may be used for testosterone replacement therapy in hypogonadal men, in HIV-wasting syndrome, and in other conditions in order to increase nitrogen retention and fat-free muscle mass. (NCI04) ( NCI )] (UMLS (CSP) C0027368) =Steroid; Pharmacologic Substance; Hormone =Estrenes;
[HS100] ANDROGENS/ANABOLICS =NANDROLONE DECANOATE;
NANDROLONE PHENPROPIONATE;
NANDROLONE DECANOATE;
NANDROLONE PHENPROPIONATE;
| - 888. 1pm
- [Maxillary right third molar mesial prosthesis ( HL7V3.0 )] (UMLS (HL7) C1552211) =Medical Device =Artificial dentition;
|
- 839. 19a
- [Mandibular left first molar abutment ( HL7V3.0 )] (UMLS (HL7) C1553655) =Medical Device =Artificial dentition;
| - 889. 1q
- [Distal (long) arm of chromosome 1 ( NCI )] (UMLS (NCI) C1327882) Chromosome 1 Distal Arm;
Chromosome 1 Long Arm;
Chromosome 1q;
=Nucleotide Sequence ;
|
- 840. 19ad
- [Mandibular left first molar abutment distal hemisection ( HL7V3.0 )] (UMLS (HL7) C1553657) =Medical Device =Artificial dentition;
| - 890. 1s
- [Supernumerary maxillary right third molar ( HL7V3.0 )] (UMLS (HL7) C1552115) =Body Part, Organ, or Organ Component =SUPERNUMERARY TEETH;
|
- 841. 19am
- [Mandibular left first molar abutment mesial hemisection ( HL7V3.0 )] (UMLS (HL7) C1553656) =Medical Device =Artificial dentition;
| - 891. 1ST DEG BURN ABDOMN WALL
- [ ] (UMLS (ICD9CM) C0840797) Erythema due to burn [first degree] of abdominal wall =Injury or Poisoning
|
- 842. 19d
- [Mandibular left first molar distal hemisection ( HL7V3.0 )] (UMLS (HL7) C1552108) =Body Part, Organ, or Organ Component =Permanent dentition;
| - 892. 1ST DEG BURN ANKLE
- [ ] (UMLS (ICD9CM) C0161274) =Injury or Poisoning
|
- 843. 19i
- [Mandibular left first molar implant ( HL7V3.0 )] (UMLS (HL7) C1552187) =Medical Device =Artificial dentition;
| - 893. 1ST DEG BURN ARM NOS
- [ ] (UMLS (ICD9CM) C0161157) =Injury or Poisoning
|
- 844. 19id
- [Mandibular left first molar implant distal hemisection ( HL7V3.0 )] (UMLS (HL7) C1552189) =Medical Device =Artificial dentition;
| - 894. 1ST DEG BURN ARM-MULT
- [ ] (UMLS (ICD9CM) C0161164) =Injury or Poisoning
|
- 845. 19im
- [Mandibular left first molar implant mesial hemisection ( HL7V3.0 )] (UMLS (HL7) C1552188) =Medical Device =Artificial dentition;
| - 895. 1ST DEG BURN AXILLA
- [ ] (UMLS (ICD9CM) C0161161) =Injury or Poisoning
|
- 846. 19m
- [Mandibular left first molar mesial hemisection ( HL7V3.0 )] (UMLS (HL7) C1552107) =Body Part, Organ, or Organ Component =Permanent dentition;
| - 896. 1ST DEG BURN BACK
- [ ] (UMLS (ICD9CM) C0840798) Erythema due to burn [first degree] of back [any part] =Injury or Poisoning
|
- 847. 19p
- [Mandibular left first molar prosthesis ( HL7V3.0 )] (UMLS (HL7) C1553592) =Body Part, Organ, or Organ Component =Artificial dentition;
| - 897. 1ST DEG BURN BREAST
- [ ] (UMLS (ICD9CM) C0161109) =Injury or Poisoning
|
- 848. 19pd
- [Mandibular left first molar distal prosthesis ( HL7V3.0 )] (UMLS (HL7) C1553591) =Medical Device =Artificial dentition;
| - 898. 1ST DEG BURN CHEST WALL
- [ ] (UMLS (ICD9CM) C0161110) =Injury or Poisoning
|
- 849. 19pm
- [Mandibular left first molar mesial prosthesis ( HL7V3.0 )] (UMLS (HL7) C1553593) =Medical Device =Artificial dentition;
| - 899. 1ST DEG BURN CHIN
- [ ] (UMLS (ICD9CM) C0433307) =Injury or Poisoning
|
- 850. 19s
- [Supernumerary mandibular left first molar ( HL7V3.0 )] (UMLS (HL7) C1552133) =Body Part, Organ, or Organ Component =SUPERNUMERARY TEETH;
| - 900. 1ST DEG BURN EAR
- [ ] (UMLS (ICD9CM) C0161046) =Injury or Poisoning
|
home
